US Patent Issued to Nanjing GenScript Biotech on Sept. 15 for "Anti-CD47/anti-LAG-3 bispecific antibody, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,480, issued on Sept. 15, was assigned to Nanjing GenScript Biotech Co. Ltd. (Nanjing, China).

"Anti-CD47/anti-LAG-3 bispecific antibody, preparation method therefor and use thereof" was invented by Liusong Yin (Jiangsu, China), Zhongdao Li (Jiangsu, China), Tielin Zhou (Jiangsu, China) and Zhuo Fang (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are an anti-CD47/anti-LAG-3 bispecific antibody, a preparation method thereof and a use thereof. The bispecific antibody comprises (a) a first antigen binding portion, which comprises a heavy chain variable region (VH) and a light chain variable region (VL), wherein VH and VL form ...